Boston Scientific (BSX)

EBITDA Margin

27.64%

TTM · Period ending:

BSX logo

BSX EBITDA Margin

Latest reported27.64%
BSX TTM EBITDA Margin (30.68% → 27.64%)
High-resolution chart · PNG

BSX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Boston Scientific EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
25.7645%
30.125%
32.1321%
33.1389%
31.2365%
31.7099%
32.0549%
4.3313%
3.8486%
-0.7445%
-5.7933%
19.3514%
20.07%
21.5986%
22.527%
22.6885%
23.1438%
27.0211%
32.4966%
34.3348%
35.6728%
31.5564%
25.7543%
33.3459%
32.3582%
31.1941%
28.9532%
29.4282%
29.7888%
30.1715%
30.2368%
29.6449%
30.0057%
30.3167%
30.9327%
-8.4521%
3.4483%
16.6931%
30.6823%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.